Skip to main content
. 2021 Nov 16;10(11):1402. doi: 10.3390/antibiotics10111402

Table 5.

Resistance and susceptibility of 105 Gram-negative bacteria.

A. baumannii
p < 0.0001 * (C)
Colistin ***, p < 0.0001 (Z)
Tigecycline ***, p = 0.0002 (Z)
C. freundii
p = 0.52 (C)
E. aerogenes
p = 0.92 (C)
E. cloacae
p = 0.0094 * (C)
Amoxicillin
clavulanic acid **, p = 0.0039 (Z)
E. coli
p < 0.0001 *(C)
Ampicillin **, p < 0.0001 (Z)
Cefotaxime **, p = 0.0015 (Z)
Ciprofloxacin **, p = 0.0002 (Z)
Amikacin ***, p = 0.0105 (Z)
Imipenem ***, p = 0.0318 (Z)
Meropenem ***, p = 0.0105 (Z)
Ertapenem ***, p = 0.0416 (Z)
K. oxytoca
p = 0.33 (C)
K. pneumoniae
p < 0.0001* (C)
Amoxicillin clavulanic acid **, p = 0.021 (Z)
Ampicillin **, p = 0.0391 (Z)
Piperacillin tazobactam **, p = 0.021 (Z)
Cefotaxime **, p = 0.0058 (Z)
Ceftazidime **, p = 0.0058 (Z)
Ciprofloxacin **, p = 0.0058 (Z)
Colistin ***, p < 0.0001 (Z)
Fosfomycin ***, p = 0.0238 (Z)
Tigecycline ***, p < 0.0001 (Z)
Trimethoprim-sulfamethoxazole ***, p < 0.0001 (Z)
P. mirabilis
p = 0.37 (C)
P. aeruginosa
p = 0.49 (C)
S. marcescens
p = 0.0142 * (C)
Amoxicillin clavulanic acid **, p = 0.0181 (Z)
Colistin **, p = 0.0181 (Z)

* = Significant test; ** = most frequent bacteria; C = multicomparison chi-squared test; Z = post-hoc Z-test; ** antibiotic more resistant; *** antibiotic more susceptible.